HOME >> BIOLOGY >> NEWS
False Security: You Can't Always Believe The Results Of A Genetic Test

Many laboratories offering genetic tests for cystic fibrosis don't test for enough mutations to give reliable results, according to a new study.

Last year, a panel convened by the US National Institutes of Health (NIH) recommended that prospective parents be routinely offered tests to see if they carry mutations that could give their children cystic fibrosis. This was the first time a genetic test had been recommended for the general population (This Week, 26 April 1997, p 12). The new findings, from a team of geneticists led by Wayne Grody of the University of California at Los Angeles, suggest that this recommendation was premature.

Cystic fibrosis, in which the lungs and airways become clogged with mucus and prone to infections, is caused by defects in a single large gene. There are hundreds of these mutations. Some are very rare, and certain mutations are more common in particular ethnic groups.

To be effective, the widespread screening urged by the NIH panel would have to test for many of the most common mutations. Exactly how many is still a matter of debate. "One thing that was conspicuously lacking from the panel's recommendation was how many mutations should be tested for," says Grody, who is co-chair of a committee drawing up guidelines on the issue for the American College of Medical Genetics (ACMG). To identify 90 per cent or more of people carrying cystic fibrosis genes, it may be necessary to test for 20 of the most common mutations, Grody predicts.

Grody also leads a team of geneticists monitoring the testing labs on behalf of the ACMG and the College of American Pathologists. The team's latest survey, published in The American Journal of Human Genetics (vol 62, p 1252), reveals a disturbing picture. The investigators asked 45 labs how many mutations in the cystic fibrosis gene they usually test for. Forty-three responded, reporting numbers ranging from just one to 70. It was most co
'"/>

Contact: Claire Bowles
Claire Bowles@rbi.co.uk
01 71 331-2751
New Scientist
20-May-1998


Page: 1 2

Related biology news :

1. Cant stand the pain? Your genes may be to blame
2. If You Cant Stop Polluting, Try Changing The Weather Instead
3. As A Carbon Sponge, Iron-Poor Coastal Waters Cant Always Do The Job, NaturePaper Shows
4. The Commons: Not Always A Tragedy
5. Once A Bully, Always A Bully, Invasive Non-Native Plants Tend To Be Aggressive Wherever They Find Themselves
6. Chemical Reaction Believed To Support Underground Microbes Is Now Unlikely
7. Results of pivotal study for GlaxoSmithKlines Valtrex published in New England Journal of Medicine
8. Results from open-label Raptiva study suggest continued benefit with long-term treatment
9. NASA Materials Conference Features Science Results, Experts on Technologies for Exploration
10. Abgenix Reports Encouraging Preclinical Results With ABX-EGF In Cancer Research
11. Encouraging Results In Preclinical Studies Of Parkinsons Disease Gene Therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2019)... Calif. (PRWEB) , ... March 22, 2019 , ... ... Preparation Kit for Next Generation Sequencing (NGS) sample preparation. RhinoSeq employs a proprietary ... NGS market. The five-tube kit is comprised of preformatted master mixes for a ...
(Date:3/18/2019)... , ... March 18, 2019 , ... Periodontal disease, where ... loss, affects nearly 50% of the US population. Making this disease particularly challenging ... biofilm state, where the cells are enmeshed in a sticky extracellular material that makes ...
(Date:3/18/2019)... ... March 18, 2019 , ... ... leader in microbial solutions announce today they have entered into an agreement for ... breakthrough product for biologic nitrogen fixation for corn. This agreement ensures an easy-to-use ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ALISO VIEJO, Calif. (PRWEB) , ... March 19, ... ... subsidiary of Konica Minolta, Inc. (Konica Minolta) today announced the formation of their ... dedicated to the advancement of precision medicine that takes into account individual variability ...
(Date:3/15/2019)... PAULO and ATLANTA (PRWEB) , ... ... ... completed the acquisition of 100% equity in American Process Inc. and affiliate ... include the Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D ...
(Date:3/14/2019)... ... 2019 , ... Murrieta Genomics , the genomic sequencing business incubator, has ... business experience to bear as genomic sequencing startups build their business models. , “We ... that our Advisory Board brings to the table. Many of these experts would be ...
(Date:3/11/2019)... (PRWEB) , ... March 11, 2019 , ... In this ... considered to improve your clinical trial efficiency and experience. Participants will learn how to ... clinical IRT expertise to ensure that the simple or complex randomization scheme is properly ...
Breaking Biology Technology:
Cached News: